MICA Ester CAS 246035-38-1 Purity ≥99.0% (HPLC) Cefixime Intermediate

Short Description:

Name: MICA Ester

CAS: 246035-38-1

Purity: ≥99.0% (HPLC)

Appearance: Orange Crystalline Powder

Usage: Intermediate of Cefixime, Carumonam

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Supply, High Purity, Commercial Production
Chemical Name: MICA Ester CAS 246035-38-1
CAS: 246035-38-1

Chemical Properties:

Chemical Name	(S)-2-Benzothiazolyl (Z)-2-(2-aminothiazole-4-yl)-2-methoxycarbonylmethoxyiminothioacetate
Synonyms	MICA Ester
CAS Number	246035-38-1
CAT Number	RF-PI562
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C15H12N4O4S3
Molecular Weight	408.48
Melting Point	102.0 to 104.0℃
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Orange Crystalline Powder
Purity / Analysis Method	≥99.0% (HPLC)
Assay / Analysis Method	≥99.0% (Titration)
Loss on Drying	≤0.50%
Ash	≤0.50%
Related Substances
MBT	≤0.50%
MICA Acid	≤0.50%
Maximum Single Impurity	≤0.50%
Total Impurities	≤1.0%
Test Standard	Enterprise Standard
Usage	Intermediate of Cefixime (CAS 79350-37-1) Carumonam (CAS 87638-04-8)

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

Advantages:

FAQ:

Application:

(S)-2-Benzothiazolyl (Z)-2-(2-aminothiazole-4-yl)-2-methoxycarbonylmethoxyiminothioacetate (CAS: 246035-38-1) ,Synonyms: MICA Ester, intermediate of Cefixime (CAS: 79350-37-1) Carumonam (CAS: 87638-04-8). MICA Ester is the side chain of Cefixime. Cefixime is a third-generation oral cephalosporin antibiotic, also known as Oroken, Suprax, Cefspan, in clinic used for the treatment of bacterial infectious diseases caused by Streptococcus (except Enterococci), Pneumonia chain, Neisseria gonorrhoeae, Escherichia coli, Branhamella catarrhalis, Serratia bacteria, Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Haemophilus influenzae, Klebsiella, Serratia, Proteus and Haemophilus Influenzae, etc.

Canunonam is an injectable antibiotic, the second monobactam ever developed (the first being Squibb’s aztreonam). It is highly active against Gram negative bacteria, particularly pseudomom, and is reportedly effective in the treatment of pneumonia, cystitis, peritonitis and secondary infections.